Cargando…
Omapatrilat normalizes renal function curve in spontaneously hypertensive rats
BACKGROUND: The present study was designed to analyze the chronic renal response to omapatrilat, a new vasopeptidase inhibitor, in spontaneously hypertensive rats (SHR). To that end, the renal and blood pressure response to a 4-day salt loading protocol was analyzed and the respective chronic renal...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC57752/ https://www.ncbi.nlm.nih.gov/pubmed/11592920 http://dx.doi.org/10.1186/1471-2210-1-5 |